Drastic loss after stabilization for 5 years of DHT blockers, topical minoxidil, nizoral shampoo
    Update 3/29/2025

    From the encyclopedia
    Dutasteride β†’

    Heavy duty finasteride that comes with higher risks

    Minoxidil β†’

    An essential vasodilator with some anti-androgenic effects

    Vitamin D β†’

    vitamin you should probably be taking for general health might also help your hair a little

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    πŸ’Š Dutasteride (oral) 0.5mg daily 5 years
    πŸ’§ Minoxidil (topical) nightly 5 years
    πŸ’§ Nizoral shampoo (topical) a few times per week
    πŸ’Š Vitamin D (oral) several weeks
    πŸ’Š Zinc (oral) starting
    the tone is 😞 negative.

    Other terms

    A 27-year-old is experiencing significant hair loss despite using a combination of 0.5mg dutasteride daily, topical minoxidil, nizoral shampoo, and vitamin D optimization, and is now starting zinc supplementation. Suggestions include considering other causes, possibly increasing dutasteride dosage, switching to oral minoxidil, or maintaining the current regimen and reassessing in six months.
    View this post in the Community β†’

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      research Antiandrogens and Androgen Inhibitors

      November 2020 in “Elsevier eBooks”
      This source outlines various antiandrogen and androgen inhibitor drugs used to treat cutaneous disorders of hyperandrogenism, detailing their mechanisms, uses, dosages, and side effects, with emphasis on spironolactone, finasteride, dutasteride, and oral contraceptives.
      Antiandrogen Therapy in Dermatology

      research ANTIANDROGEN THERAPY IN DERMATOLOGY

      32 citations , November 1996 in “International Journal of Dermatology”
      This review discusses the use of antiandrogen therapy in dermatology, covering treatments for conditions like acne, hirsutism, and androgenic alopecia but reports no new clinical findings.
      Androgen Excess: Investigations and Management

      research Androgen excess: Investigations and management

      82 citations , May 2016 in “Best Practice & Research in Clinical Obstetrics & Gynaecology”
      This article outlines the clinical features, evaluation, and treatment strategies for androgen excess in polycystic ovary syndrome, highlighting important diagnostic and management approaches but reporting no new research results.
      Alopecia: Managing the Basics

      research Alopecia: managing the basics

      July 2015 in “Cambridge University Press eBooks”
      The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.
      Androgenetic Alopecia: A Review and Emerging Treatments

      research Androgenetic Alopecia: a Review and Emerging Treatments

      1 citations , July 2017 in “Clinical research in dermatology”
      This review covers the pathogenesis, diagnosis, and potential new treatments for androgenetic alopecia but reports no new clinical findings, highlighting an ongoing need for effective therapies.